Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8977 - 8984 of 11454 results
British Columbia Provides Model for Massachusetts Carbon Pricing
April 16, 2015| Blog| Viewpoint
DOJ’s Endorsement of IEEE Patent Policy Takes Center Stage at IP Antitrust Conference
April 16, 2015| Alert| Viewpoint
UPDATE: Target Confirms It Has Negotiated A $19 Million Data Breach Settlement With MasterCard
April 16, 2015| Blog| Viewpoint
DOJ Emphasizes Role of Criminal Prosecution in Addition to Regulatory Enforcement
April 16, 2015| Blog| Viewpoint
FDA Increasing Scrutiny of Cosmetic Marketing Claims, New Agency Warnings Suggest
April 16, 2015| Blog| Viewpoint
Mintz Welcomes Joanne Hawana to its FDA and Health Law Practices
April 16, 2015| Blog| Viewpoint
CMS Provides Guidance to States on Managed Care Contract Review
April 16, 2015| Blog| Viewpoint
DOJ Guidance on IEEE Letter Hotly Debated
April 16, 2015| Blog| Viewpoint
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.